3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Breast Neoplasms
8
Neoplasms
5
Anxiety Disorders
4
Pain
3
Lung Neoplasms
3
Sleep Initiation and Maintenance Disorders
2
Polycystic Ovary Syndrome
2
Obesity
2
Neuropathy, Painful
2
Fatigue
2
Depression
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Stress, Psychological
1
Squamous Intraepithelial Lesions
1
Signs and Symptoms
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Papillomavirus Infections
1
Overweight
1
Ovarian Neoplasms
1
Neurobehavioral Manifestations
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Lymphoma
1
Hot Flashes
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
Cyclophosphamide
25
Rituximab
18
fludarabine phosphate
15
Radiotherapy
13
Methotrexate
13
Peripheral Blood Stem Cell Transplantation
12
Filgrastim
12
Cytarabine
12
Vincristine
11
Melphalan
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Exercise
9
Doxorubicin
9
Prednisone
7
Mycophenolic Acid
7
Magnetic Resonance Spectroscopy
7
Etoposide
7
Early Intervention, Educational
7
Whole-Body Irradiation
6
Surveys and Questionnaires
6
Prednisolone
6
Palliative Care
6
Methods
6
Leucovorin
6
Educational Status
6
Blood Specimen Collection
6
Dexamethasone
5
pegylated granulocyte colony-stimulating factor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma
×
Mindfulness-Based Stress Reduction
×
Clear all
NCT06063603
2025-09-18
ASCENT
Mayo Clinic
Phase NA
Completed
51 enrolled
8 charts